Ann-Sophie Bohne

Universitätsklinikum Schleswig-Holstein Campus Kiel

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Claus Garbe

Professor of Dermatology

Eberhard Karls Universität Tübingen

GERMANY

View details

Alexander Christopher Jonathan van Akkooi

Associate Professor

Melanoma Institute Australia

AUSTRALIA

View details

Andreas Hutloff

Professor

University Hospital Schleswig-Holstein

GERMANY

View details

Maria Concetta Fargnoli

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ann-Sophie Bohne

Research Interests

Explore related searches

Contact this professor

Articles (10)

Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma.

Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

["Red flags" during pregnancy-skin symptoms and their causes during pregnancy].

Facets of pemphigoid: Localized scarring Brunsting-Perry pemphigoid.

Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications.

Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab

Rheumatoid neutrophilic dermatosis under treatment with the interleukin‐6‐receptor‐antagonist sarilumab in a patient with seropositive rheumatoid arthritis

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial).

[DMARD treatment and skin cancer : Recognition, state of knowledge and prevention].

Collaborators (4)

Claus Garbe

Alexander Christopher Jonathan van Akkooi

Andreas Hutloff

Maria Concetta Fargnoli

Make your next move.